← Open Payments lookup

JAMES HAROLD: Open Payments

NPI 1760543482 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$5,737 in 246 payments from 18 companies in 2025. Trend: 2023 $30,126 · 2024 $1,183 · 2025 $5,737

Food & beverage: $5,617Education: $120
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.34$820
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)29$710
ABBVIE INC.45$685
Neurocrine BioSciences, Inc.20$656
Teva Pharmaceuticals USA, Inc.17$600
Axsome Therapeutics, Inc.22$551
Janssen Pharmaceuticals, Inc10$329
E.R. Squibb & Sons, L.L.C.10$255
Alkermes, Inc.11$247
Vanda Pharmaceuticals Inc.14$237

Products named: REXULTI, CAPLYTA, VRAYLAR, INGREZZA, Auvelity, AUSTEDO XR, COBENFY, INVEGA SUSTENNA.

Industry payments across TX — which companies pay providers there.